EMEA-000181-PIP02-13-M01
Key facts
Invented name |
Sativex
|
Active substance |
|
Therapeutic area |
Pain
|
Decision number |
P/0373/2022
|
PIP number |
EMEA-000181-PIP02-13-M01
|
Pharmaceutical form(s) |
Oromucosal spray
|
Condition(s) / indication(s) |
Treatment of pain
|
Route(s) of administration |
Oromucosal use
|
Contact for public enquiries |
GW Pharma Ltd
United Kingdom |
Decision type |
PM: decision on the application for modification of an agreed PIP
|